A Phase 2 Study of Abemaciclib in Patients (PTS) with Brain Metastases (BM) Secondary to HR+, HER2-Metastatic Breast Cancer (MBC)

被引：0

作者：

Anders, Carey ^{[1
]}

Le Rhun, Emily ^{[2
]}

Bachelot, Thomas ^{[3
]}

Yardley, Denise ^{[4
]}

Awade, Ahmad ^{[5
]}

Conte, Pierre Franco ^{[6
]}

Cabos, Peter ^{[7
]}

Bear, Melissa ^{[8
]}

Tolaney, Sarah ^{[9
]}

机构：

[1] Duke Canc Inst, Durham, NC USA

[2] Univ Hosp, Lille, France

[3] Ctr Leon Berard, Lyon, France

[4] Sarah Cannon Res Inst, Nashville, TN USA

[5] Inst Jules Bordet, Brussels, Belgium

[6] Univ Padua, Padua, Italy

[7] Univ Denver, Denver, CO USA

[8] Elli Lilly, Indianapolis, IN USA

[9] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

168

引用

页码：10 / 10

页数：1